Vaccine effectiveness in symptom and viral load mitigation in COVID-19 breakthrough infections in South Korea
<h4>Objectives</h4> Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine effectiveness in coronavirus disease (COVID-19) patients with breakthrough infections has not been established in South Korea. To address this, we assessed the impact of vaccination on symptom occurr...
Main Authors: | Jieun Jang, Hyopin Jeong, Bong-Hwa Kim, Sura An, Hye-Ryun Yang, Sunjoo Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431655/?tool=EBI |
Similar Items
-
Evaluation of the Diagnostic Accuracy of Nasal Cavity and Nasopharyngeal Swab Specimens for SARS-CoV-2 Detection via Rapid Antigen Test According to Specimen Collection Timing and Viral Load
by: Seungjun Lee, et al.
Published: (2022-03-01) -
Evaluation of the T cell and B cell response following the administration of COVID-19 vaccines in Korea
by: Kristin Widyasari, et al.
Published: (2022-12-01) -
Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers
by: Ulrika Marking, et al.
Published: (2023-03-01) -
Analysis of Breakthrough Reactions in 1,143 Desensitization Procedures in a Single Tertiary Hospital Using a One-Bag Desensitization Protocol
by: Hyun Hwa Kim, et al.
Published: (2022-02-01) -
SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021
by: Seonju Yi, et al.
Published: (2022-03-01)